ribociclib
novartis
['natalee', 'pivot,io,i', 'point data', 'trion']
dennis slamon, md, trio chairman and executive director, presented positive primary endpoint data from the pivotal phase iii natalee (trio033) trial at the 2023 american society of clinical oncology asco annual meeting. 
Advancing cancer research. Life-changing results.